This tool converts an HbA1c value into an estimated average glucose (eAG), expressed in mg/dL or mmol/L. It gives a quick reference figure you can use alongside HbA1c when discussing glycaemic control with a patient.
What this tool does
The calculator takes an HbA1c percentage and returns the corresponding eAG. It is meant as a conversation aid, not a diagnostic or dosing tool. It does not replace clinical judgement, glucose logs, or continuous glucose monitoring (CGM) data.
The conversion formula
The widely used formula, from the ADAG study, is:
eAG (mg/dL) = 28.7 × HbA1c (%) − 46.7
For mmol/L, divide the mg/dL result by 18.
[source needed: ADAG study reference]
This formula is an average relationship derived from a study population. Individual patients can fall outside this line.
How to use the calculator
1. Enter the HbA1c value as a percentage (or mmol/mol if your tool supports IFCC units). 2. The calculator returns the estimated average glucose over the preceding 2–3 months. 3. Use this figure as one data point, alongside fasting glucose, post-prandial readings, or CGM time-in-range data, when reviewing control with the patient.
Limitations of the eAG estimate
- eAG is a population-average estimate. Two patients with the same HbA1c can have different actual average glucose levels. (Chehregosha H et al., Diabetes Ther 2019)
- The formula does not capture glucose variability. A patient with large swings between highs and lows can have the same HbA1c as a patient with stable, moderate glucose. (Jancev M et al., Diabetologia 2024)
- HbA1c itself can be affected by conditions unrelated to glucose control, such as haemoglobinopathies, anaemia, chronic kidney disease, and recent blood transfusion. These conditions can make HbA1c (and therefore eAG) unreliable.
- eAG reflects an average over roughly 2–3 months, weighted more toward the most recent 30 days. It is not a same-day glucose value.
Clinical factors that affect accuracy
Consider checking these before relying heavily on an eAG figure:
- Red cell lifespan: conditions that shorten or lengthen red cell survival affect HbA1c independent of glucose.
- Pregnancy: glucose targets and HbA1c interpretation differ in pregnancy. (Cowie CC et al., 2018)
- Ethnic and population differences: some studies report variation in the HbA1c–glucose relationship across groups. (Bergman M et al., Diabetes Res Clin Pract 2024)
- Recent acute illness or steroid use: these can transiently raise glucose without yet showing up fully in HbA1c.
When any of these apply, CGM data or structured self-monitoring logs are more informative than eAG alone.
Using eAG when counselling patients
Many patients find a glucose number (mg/dL or mmol/L) easier to relate to than an HbA1c percentage. The eAG conversion can help explain what a given HbA1c roughly means in day-to-day terms. It can be useful to:
- Explain targets in units the patient already tracks at home.
- Show the gap between current control and a discussed target range, without stating this as a diagnosis or a dosing instruction.
- Support shared decision-making conversations about lifestyle or monitoring frequency.
Any changes to medication or insulin dosing should follow standard clinical protocols and should not be based on the eAG figure alone.
Further reading
- Review the original ADAG study methodology before quoting the formula to patients in detail.
- Current clinical guidelines on HbA1c targets and monitoring frequency. (Kalyani RR et al., JAMA 2025)
- Guidance on HbA1c interpretation in special populations (pregnancy, haemoglobinopathies, CKD). (Sthaneshwar P et al., Med J Malaysia 2014)
This calculator is a quick-reference tool. It is built for use alongside standard clinical assessment, not as a substitute for it.